Commission Implementing Regulation (EU) 2018/1122 of 10 August 2018 authorising the placing on the market of pyrroloquinoline quinone disodium salt as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance.)
Commission Implementing Regulation (EU) 2018/1122 of 10 August 2018 authorising the placing on the market of pyrroloquinoline quinone disodium salt as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance.)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
1. Pyrroloquinoline quinone disodium salt as specified in the Annex to this Regulation shall be included in the Union list of authorised novel foods established in Implementing Regulation (EU) 2017/2470.
2. For a period of five years from the date of entry into force of this Regulation only the initial Applicant:
Company: Mitsubishi Gas Chemical Company, Inc.
Address: Mitsubishi Building 5-2 Marunouchi 2-chome, Chiyoda-ku, Tokyo 100-8324, Japan
is authorised to place on the market within the Union the novel food referred to in paragraph 1, unless a subsequent applicant obtains authorisation for the novel food without reference to the data protected pursuant to Article 2 of this Regulation or with the agreement of Mitsubishi Gas Chemical Company, Inc.
3. The entry in the Union list referred to in the first paragraph shall include the conditions of use and labelling requirements laid down in the Annex to this Regulation.
4. The authorisation provided for in this Article shall be without prejudice to the provisions of Directive 2002/46/EC.
The studies contained in the application file on the basis of which the novel food referred to in Article 1 has been assessed by the Authority, claimed by the applicant as proprietary and without which the data protection could not have been authorised, shall not be used for the benefit of a subsequent applicant for a period of five years from the date of entry into force of this Regulation without the agreement of Mitsubishi Gas Chemical Company, Inc.
ANNEX
The Annex to Implementing Regulation (EU) 2017/2470 is amended as follows:
(1)
the following last column is added in Table 1 (Authorised novel foods):
‘Data Protection’
(2)
The following entry is inserted in Table 1 (Authorised novel foods) in alphabetical order:
Authorised novel food
Conditions under which the novel food may be used
Additional specific labelling requirements
Other requirements
Data Protection
‘ Pyrroloquinoline quinone disodium salt
Specified food category
Maximum levels
The designation of the novel food on the labelling of the foodstuffs containing it shall be “Pyrroloquinoline quinone disodium salt”.
Food supplements containing Pyrroloquinoline quinone disodium salt shall bear the following statement:
This food supplement should be consumed by adults only excluding pregnant and lactating women
Authorised on 2 September 2018. This inclusion is based on proprietary scientific evidence and scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283.
Applicant: Mitsubishi Gas Chemical Company, Inc., Mitsubishi Building 5-2 Marunouchi 2-chome, Chiyoda-ku, Tokyo 100-8324, Japan. During the period of data protection the novel food Pyrroloquinoline quinone disodium salt is authorised for placing on the market within the Union only by Mitsubishi Gas Chemical Company, Inc., unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Mitsubishi Gas Chemical Company, Inc.
End date of the data protection: 2 september 2023’
Food Supplements as defined in Directive 2002/46/EC intended for the adult population, excluding pregnant and lactating women
20 mg/day
(3)
The following entry is inserted in Table 2 (Specifications) in alphabetical order:
Authorised Novel Food
Specification
‘ Pyrroloquinoline quinone disodium salt
Definition:
Chemical name: disodium 9-carboxy-4,5-dioxo-1 H -pyrrolo[5,4-f]quinoline-2,7-dicarboxylate
Chemical formula: C 14 H 4 N 2 Na 2 O 8
CAS No: 122628-50-6
Molecular weight: 374,17 Da
Description
Pyrroloquinoline quinone disodium salt is a reddish–brown powder produced by the non-genetically modified bacterium Hyphomicrobium denitrificans strain CK-275.
Characteristics/Composition
Appearance: Reddish-brown powder
Purity: ≥ 99,0 % (dry weight)
UV absorbance (A322/A259): 0,56 ± 0,03
UV absorbance (A233/A259): 0,90 ± 0,09
Moisture: ≤ 12,0 %
Residual Solvent
Ethanol: ≤ 0,05 %
Heavy metals
Lead: < 3 mg/kg
Arsenic: < 2 mg/kg
Microbiological criteria:
Total viable cell count: ≤ 300 CFU/g
Mould/yeast: ≤ 12 CFU/g
Coliforms: absent in 1 g
Hyphomicrobium denitrificans : ≤ 25 CFU/g
CFU: Colony Forming Units’
